EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 103 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,998 | -78.9% | 29,498 | -51.4% | 0.00% | – |
Q2 2023 | $42,724 | -35.1% | 60,688 | -17.3% | 0.00% | – |
Q1 2023 | $65,831 | -93.3% | 73,399 | -91.1% | 0.00% | – |
Q4 2022 | $978,194 | -73.6% | 828,977 | +68.6% | 0.00% | -100.0% |
Q3 2022 | $3,702,000 | -34.5% | 491,786 | -45.2% | 0.00% | 0.0% |
Q2 2022 | $5,652,000 | -52.1% | 897,213 | -36.9% | 0.00% | -50.0% |
Q1 2022 | $11,805,000 | +441.3% | 1,422,278 | +238.5% | 0.00% | – |
Q4 2021 | $2,181,000 | +198.8% | 420,149 | +284.8% | 0.00% | – |
Q3 2021 | $730,000 | -25.9% | 109,174 | -5.5% | 0.00% | – |
Q2 2021 | $985,000 | +103.9% | 115,488 | +111.4% | 0.00% | – |
Q1 2021 | $483,000 | +64.8% | 54,618 | +128.9% | 0.00% | – |
Q4 2020 | $293,000 | +614.6% | 23,865 | +376.2% | 0.00% | – |
Q3 2020 | $41,000 | -84.5% | 5,012 | -81.8% | 0.00% | – |
Q2 2020 | $264,000 | +103.1% | 27,500 | +43.6% | 0.00% | – |
Q1 2020 | $130,000 | -75.5% | 19,152 | -46.1% | 0.00% | – |
Q4 2019 | $530,000 | +395.3% | 35,536 | +242.2% | 0.00% | – |
Q3 2019 | $107,000 | -33.5% | 10,386 | -31.5% | 0.00% | – |
Q2 2019 | $161,000 | -81.4% | 15,169 | -75.5% | 0.00% | – |
Q1 2019 | $867,000 | +61.2% | 62,026 | +17.3% | 0.00% | – |
Q4 2018 | $538,000 | +323.6% | 52,880 | +399.5% | 0.00% | – |
Q3 2018 | $127,000 | -63.4% | 10,587 | -62.7% | 0.00% | – |
Q2 2018 | $347,000 | +9.8% | 28,405 | -11.6% | 0.00% | – |
Q1 2018 | $316,000 | +79.5% | 32,150 | +154.8% | 0.00% | – |
Q4 2017 | $176,000 | +6.0% | 12,619 | -16.5% | 0.00% | – |
Q3 2017 | $166,000 | +33.9% | 15,119 | -3.6% | 0.00% | – |
Q2 2017 | $124,000 | -1.6% | 15,681 | +43.0% | 0.00% | – |
Q1 2017 | $126,000 | -55.3% | 10,968 | -54.8% | 0.00% | – |
Q4 2016 | $282,000 | +2463.6% | 24,266 | +2698.8% | 0.00% | – |
Q3 2016 | $11,000 | +450.0% | 867 | +767.0% | 0.00% | – |
Q2 2016 | $2,000 | -88.2% | 100 | -90.0% | 0.00% | – |
Q1 2016 | $17,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
DRW Securities, LLC | 120,365 | $37 | 0.00% |
DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |